2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Azam Usman | — | 1,875,000 | Oct 2, 2025 |
| Passeri Daniel R | CEO | 164,578 | Dec 18, 2024 |
| Suri Anish | President | 150,000 | Jun 7, 2024 |
| Warren Lucinda | — | 125,000 | Nov 25, 2025 |
| Levisetti Matteo | — | 125,000 | Jun 7, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 6, 2026 | Kiener Peter A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Broadfoot Jill Marie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Garzone Pamela | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Verheyen Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Sarraf Pasha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 30, 2025 | Jan 2, 2026 | Sarraf Pasha | Director | Buy | 95.0 | +323,857 | 100.00% | ✗ | $99.7K |
| Sep 26, 2025 | Dec 5, 2025 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2025 | Nov 25, 2025 | Warren Lucinda | CHIEF BUSINESS OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2025 | Nov 25, 2025 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2025 | Oct 2, 2025 | Azam Usman | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 2, 2025 | Azam Usman | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 4, 2025 | Jun 6, 2025 | Broadfoot Jill Marie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2025 | Broadfoot Jill Marie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 21, 2025 | Mar 25, 2025 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | PASSERI DANIEL R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Warren Lucinda | CHIEF BUSINESS OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | Sarraf Pasha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2025 | Sarraf Pasha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2025 | Jan 3, 2025 | Verheyen Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Garzone Pamela | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Kiener Peter A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 16, 2024 | Dec 18, 2024 | PASSERI DANIEL R | CEO | Buy | 91.3 | +30,000 | 22.29% | ✗ | $30.9K |
| Nov 25, 2024 | Nov 29, 2024 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 29, 2024 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 5, 2024 | Warren Lucinda | CHIEF BUSINESS OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 3, 2024 | Sep 5, 2024 | Warren Lucinda | CHIEF BUSINESS OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 7, 2024 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 7, 2024 | Suri Anish | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 7, 2024 | Fox Michael J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 7, 2024 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 7, 2024 | Fox Michael J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 5, 2024 | Jun 7, 2024 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Mar 8, 2024 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Mar 8, 2024 | Suri Anish | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Mar 8, 2024 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Mar 8, 2024 | PASSERI DANIEL R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Mar 8, 2024 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 20, 2024 | Feb 22, 2024 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | Garzone Pamela | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | Kiener Peter A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | Verheyen Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2023 | Aug 29, 2023 | Suri Anish | President | Buy | 83.8 | +4,000 | 3.04% | ✗ | $11K |
| Aug 14, 2023 | Aug 16, 2023 | PASSERI DANIEL R | CEO | Buy | 77.5 | +3,000 | 2.28% | ✗ | $8.6K |
| Jul 21, 2023 | Jul 25, 2023 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | PASSERI DANIEL R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Suri Anish | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2023 | Garzone Pamela | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 19, 2023 | Apr 21, 2023 | Garzone Pamela | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 13, 2023 | Verheyen Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 11, 2023 | Apr 13, 2023 | Verheyen Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 23, 2023 | Mar 27, 2023 | Kiener Peter A | Director | Sell | 26.3 | -9,325 | -96.31% | ✗ | $30.6K |
| Feb 16, 2023 | Feb 21, 2023 | NASSHORN PATRICIA | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 21, 2023 | Suri Anish | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 21, 2023 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 21, 2023 | PASSERI DANIEL R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 21, 2023 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 17, 2023 | Jan 19, 2023 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 19, 2023 | Levisetti Matteo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 3, 2023 | Jan 5, 2023 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 5, 2023 | Kiener Peter A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 5, 2023 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 5, 2023 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 5, 2023 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 21, 2022 | Aug 23, 2022 | Millar Kerri-Ann | CFO | Sell | 27.5 | -2,828 | -16.50% | ✗ | $8.6K |
| Jun 14, 2022 | Jun 16, 2022 | Gray Cameron | Director | Sell | 22.5 | -51,562 | -6.98% | ✗ | $165K |
| May 27, 2022 | May 31, 2022 | Morich Frank | Director | Buy | 95.0 | +28,000 | 100.00% | ✗ | $105K |
| May 23, 2022 | May 25, 2022 | Fletcher Aaron G.L. | Director | Buy | 97.5 | +205,000 | 22.56% | ✗ | $711.7K |
| Mar 31, 2022 | Apr 4, 2022 | Suri Anish | President | Sell | 26.3 | -7,068 | -6.38% | ✗ | $34.5K |
| Mar 31, 2022 | Apr 4, 2022 | PASSERI DANIEL R | CEO | Sell | 22.5 | -42,122 | -24.25% | ✗ | $156.8K |
| Mar 31, 2022 | Apr 4, 2022 | Fletcher Aaron G.L. | Director | Buy | 100.0 | +735,000 | 422.74% | ✗ | $3.5M |
| Mar 25, 2022 | Mar 29, 2022 | NASSHORN PATRICIA | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2022 | Mar 29, 2022 | Suri Anish | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2022 | Mar 29, 2022 | Sandercock Colin | SVP, GENERAL COUNSEL | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2022 | Mar 29, 2022 | Pienta Kenneth | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2022 | Mar 29, 2022 | PASSERI DANIEL R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2022 | Mar 29, 2022 | Millar Kerri-Ann | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | Kiener Peter A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2022 | Jan 5, 2022 | Gray Cameron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 15, 2021 | Jan 4, 2022 | NASSHORN PATRICIA | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 4, 2022 | NASSHORN PATRICIA | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 20, 2021 | Dec 21, 2021 | Pienta Kenneth | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 15, 2021 | Nov 17, 2021 | Kiener Peter A | Director | Sell | 7.5 | -20,176 | -100.00% | ✓ | $361.7K |
| Nov 15, 2021 | Nov 17, 2021 | Suri Anish | President | Sell | 28.8 | -8,000 | -7.84% | ✓ | $144.4K |
| Nov 11, 2021 | Nov 15, 2021 | Suri Anish | President | Sell | 17.5 | -20,000 | -17.54% | ✓ | $301.4K |
| Sep 30, 2021 | Oct 8, 2021 | PASSERI DANIEL R | CEO | Sell | 20.0 | -31,677 | -24.30% | ✗ | $461.5K |
| Oct 3, 2021 | Oct 8, 2021 | Suri Anish | President | Sell | 22.5 | -14,134 | -13.07% | ✗ | $183.3K |